NMI Notes

NMI Notes

Overall Updates

NNDSS

Have You Upgraded to PHINMS 3.1?

  • If you have not already done so, please upgrade to PHIN Messaging System (PHINMS) 3.1, the latest version of PHINMS.
  • Due to security risks, PHINMS will be able to accept messages sent only using TLS 1.2, which requires PHINMS 3.1.
  • After June 30, 2019, the CDC PHINMS receiver will reject messages sent using TLS 1.0 or TLS 1.1.
  • Many jurisdictions have already upgraded and are successfully using the new PHINMS software.
  • Upgrading to TLS 1.2 is not complex; however, if you face challenges, both the PHINMS 3.1 installation guides and helpdesk support are readily available at the PHINMS website.
  • For help, contact the PHIN helpdesk at phintech@cdc.gov or 1-800-532-9929.

 2018 CSTE Position Statements to be Implemented in 2019

  • CSTE approved nine position statements in 2018:
    • One new nationally notifiable disease (Candida auris, clinical)
    • Case definition revisions for seven nationally notifiable diseases:
      • Carbon monoxide poisoning
      • Diphtheria
      • Hepatitis A viral infection, acute
      • Salmonella Typhi infection and Salmonella Paratyphi infection
      • Yellow fever
      • Listeriosis: CSTE incurred a delay in finalizing this position statement; hence, there will be a delay in implementing the changes.
    • Two conditions were placed under standardized surveillance but not designated nationally notifiable: Candida auris, colonization/screening; respiratory syncytial virus-associated mortality.
    • One condition was placed under standardized surveillance for which only FoodNet sites are requested to send data to CDC (Yersiniosis, non-pestis).
    • For complete details on the changes from CSTE position statements and implications for sending NNDSS case notifications for 2019, please see the January 2019 NMI eSHARE presentation and webinar recording on the NMI eSHARE website.

2019 Changes to NNDSS Event Codes and Case Definitions

  • NNDSS event codes that were retired and replaced are shown below.
    Table of Retired Event Names, Retired Event Codes, Dates of Retirement, Current Event Names, and Current Event Codes

    * Please do not transmit data for condition until CDC has received Office of Management and Budget approval. When CDC receives approval, we will share the information through NNDSS communication channels and publish the updated event code list on the NNDSS HL7 Case Notification Resource Center.

  • Conditions with new NNDSS event codes or changes to the case definitions follow.
    Table of Codes, Conditions, Changes, and Type of Surveillance

    * Please do not transmit data for condition until CDC has received Office of Management and Budget approval. When CDC receives approval, we will share the information through NNDSS communication channels and publish the updated event code list on the NNDSS HL7 Case Notification Resource Center.

 NMI eSHARE Updates

  • Please join us for the February NMI eSHARE session, scheduled for Tuesday, 2/19/19, at 3:00 PM ET. The webinar will introduce cohorts—a new efficient approach to HL7 case notification technical assistance.
  • Access past eSHARE presentations and details about future events at the NMI eSHARE website.

ELC HIS Recipients Onboarding Reminder

  • Epidemiology and Laboratory Capacity Health Information System (ELC HIS) Cooperative Agreement recipients must send production data for at least five more MMGs by 8/1/19.
  • Please allow several weeks for onboarding.
  • Onboard for these MMGs now:
    • arboviral 1.3
    • generic v2
    • hepatitis
    • STD
    • congenital syphilis.
  • Onboard for these soon:
    • mumps
    • pertussis
    • varicella
    • foodborne and diarrheal diseases.

SAMS Access Reminder

  • The NMI team encourages all jurisdictions to complete the Secure Access Management Services (SAMS) proofing process and confirm their access with the MVPS support team.
  • More information about SAMS access and training may be found on the NMI website.

Production HL7 Case Notification Messages

Arboviral v1.3

  • Value set updates to the arboviral v1.3 MMG are as follows:
    • Lab Test Type: Added the value “Arboviral Antigen” (LAB721) to the “Lab Test Type (Arbovirus)” value set. This value will be used for arboviral antigen tests, such as the NS1 test for dengue. CDC can now accept case notifications with this new test type.
    • Virus Type: Added Bourbon virus, Alkhurma virus, and Heartland virus.
  • Jurisdictions should update surveillance systems with updated value sets.

Generic v2

  • Value set updates to the generic v2.0 MMG (impacts all messages) are as follows:
    • Birth Country, Country, and County
    • Case Transmission Mode: Added “Droplet transmission.”
  • Jurisdictions should update surveillance systems with updated value sets.
  • The MMG and artifacts are available on the NNDSS HL7 Case Notification Resource Center. The “PHIN VADS links to the case notification views” link on the resource center displays all of the updated value sets for a condition.
  • There are 23 jurisdictions in production for generic v2. Arizona and New Jersey are the latest states in production. Congratulations, Arizona and New Jersey!
  • Connecticut, Georgia, and Indiana are engaged in onboarding.
  • Please see the chart below, “Jurisdiction Implementation of NNDSS HL7 Case Notification Messages,” for more details.

Hepatitis

Developing HL7 Case Notification Messages

Babesiosis Message Mapping Guide (MMG) (Stage II—Pilot Test-ready)

  • CDC is updating the guide and artifacts to harmonize the information requested for clinical manifestations in the babesiosis MMG with MMGs in final status.
  • CDC is piloting this guide in conjunction with the trichinellosis and malaria MMGs.

Carbon Monoxide Poisoning (CO) MMG (Requirements Analysis)

  • CDC updated the draftMMG with 25 additional data elements.

Congenital Syphilis and STD MMGs (Stage III—Final MMG)

  • Idaho, Michigan, North Carolina, and Oregon are engaged in onboarding.
  • Final congenital syphilis and STD MMGs are available on the NNDSS HL7 Case Notification Resource Center.
  • Please use these guides to begin implementing your case notification messages in preparation for onboarding.

Foodborne and Diarrheal Diseases (FDD) MMG (Stage III—Final MMG)

Healthcare Associated Infections, Multi-Drug Resistant Organisms (HAI MDRO) MMG (Requirements Analysis)

  • CDC posted the draft MMG to the NNDSS HL7 Case Notification Resource Center for external review on 1/25/19, and the MMG is open for comment for 15 working days until 2/15/19.
  • The CSTE webinar to gather feedback from jurisdictions on the draft MMG was held on 1/30/19.

Lead Poisoning MMG (Requirements Analysis)

  • CDC completed pre-work for the childhood lead poisoning portion of the MMG.

Listeriosis MMG (Stage I—Draft)

  • CDC is evaluating what changes to the MMG are needed to support CSTE position statement 18-ID-06.

Lyme and Tickborne Rickettsial Diseases (TBRD) (Stage I—Draft)

  • No new updates at this time.

Malaria MMG (Stage IIPilot Test-ready)

  • CDC is updating the guide and artifacts to harmonize the data requested for clinical manifestations in the malaria MMG with other MMGs in final status.
  • CDC is piloting this guide in conjunction with the babesiosis and trichinellosis MMGs.

Measles MMG (Stage II—Pilot Test-ready)

  • No new updates at this time.

Mumps and Pertussis MMGs (Stage III—Final)

Respiratory and Invasive Bacterial Disease (RIBD) MMG (Stage II—Pilot Test-ready)

  • MVPS development is in progress for the RIBD MMG.
  • CDC found an overlap in data element identifiers between the RIBD and Lyme/TBRD MMGs. CDC assigned a new identifier in the RIBD MMG to resolve this issue.

Rubella and Congenital Rubella Syndrome (CRS) MMGs (Stage II—Pilot Test-ready)

  • MVPS is beginning development work on the rubella and CRS MMGs.
  • A data element identifier was changed to resolve a conflict between the generic v2.0 MMG and the CRS MMG.

Trichinellosis (Pilot Test Ready—Accelerated Development Pilot)

  • CDC is piloting this guide in conjunction with the babesiosis and malaria MMGs.

Tuberculosis (TB) and Latent Tuberculosis Infection (LTBI) MMG (Pilot Test-ready—Accelerated Development Pilot)

  • Piloting is underway.

Varicella MMG (Stage III—Final)

Resources

Resources

Jurisdiction Implementation of NNDSS HL7 Case Notification Messages

States piloting, onboarding, or in production with HL7 NNDSS case notifications.

This chart shows the status of state public health departments who are piloting, receiving technical assistance, onboarding, or in production for HL7 case notification messages developed as part of the NNDSS Modernization Initiative.

Upcoming Events

Events

NMI Notes provides monthly news updates about the National Notifiable Diseases Surveillance System (NNDSS) Modernization Initiative (NMI). It is a collaboration by the Centers for Disease Control and Prevention (CDC), Council of State and Territorial Epidemiologists (CSTE), and Association of Public Health Laboratories (APHL).

If a colleague forwarded this issue to you, we encourage you to subscribe at this linkExternal to ensure that you receive future issues of NMI Notes.

Centers for Disease Control and Prevention | Council of State and Territorial Epidemiologists |
Association of Public Health Laboratories

Ready to request technical assistance or onboarding?
Please contact edx@cdc.gov for more information.

Have questions or feedback on NMI Notes?
Email
edx@cdc.gov.

View Page In:Cdc-pdf PDF [860K]
Page last reviewed: January 30, 2019